Today, the EVP, Diag. Ops & Prod. Dev. of Heska Corp (NASDAQ: HSKA), Nancy Wisnewski, sold shares of HSKA for $243.5K.
In addition to Nancy Wisnewski, 3 other HSKA executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Heska Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $32.77 million and quarterly net profit of $2.16 million. In comparison, last year the company earned revenue of $30.38 million and had a net profit of $4.61 million. HSKA’s market cap is $793.4M and the company has a P/E ratio of 110.25. Currently, Heska Corp has an average volume of 77.72K.
Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $109.33, reflecting a -3.2% downside.
The insider sentiment on Heska Corp has been negative according to 22 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Nancy Wisnewski’s trades have generated a 12.9% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments.
